Parmax Pharma Limited - Company Profile

It is a pharma public limited company based in Hadamtala, Gujarat, India, established in 1994.

1994 Hadamtala, Gujarat, India Active

Last Updated: January 11, 2026

About Parmax Pharma Limited

Parmax Pharma Limited, a active public limited company, was established on 02 November 1994 in Hadamtala, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24231GJ1994PLC023504. Registered under ROC Roc Ahmedabad. it is listed on BSE: 540359. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹3.74 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹11.10 Cr and a net worth of ₹1.05 M. Employing 9 professional, Its leadership includes Ami Shah Rajeshbhai (Director), Nikhil Sureshchandra Uchat (Director), Umang Alkesh Gosalia (Managing Director). Past directors included Prabhudas Devrajbhai Patel, Mansukhbhai Keshavjibhai Jivani, Pramay Amritlal Chhatra. It holds ₹8.40 Cr open charges and ₹14.96 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 20, Survey No. 52, Rajkot-Gondal National Highway No. 27,, Hadamtala, Gujarat, 360311.

Company Details

CIN/LLPIN
L24231GJ1994PLC023504
Registration Number
023504
Incorporation Date
02 November 1994
Authorized Capital
₹6.00 Cr
Paid-Up Capital
₹3.74 Cr
ROC Code
Roc Ahmedabad
Listing Status
Listed (BSE: 540359)
Company Status
Active

Key Metrics

Authorised Capital ₹ 6.00 Cr as on 11-01-2026
Paid Up Capital ₹ 3.74 Cr as on 11-01-2026
Company Age 31 Year, 3 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 8.40 Cr as on 11-01-2026
Satisfied Charges ₹ 14.96 Cr as on 11-01-2026
Revenue Growth **** -28.21% (FY 2024)
Profit Growth **** -5425.72% (FY 2024)
Ebitda **** -249.54% (FY 2024)
Net Worth -98.20% (FY 2024)
Total Assets -12.96% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Parmax Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Parmax Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ami Shah Rajeshbhai	Director	17 Jun 2018	Current
Nikhil Sureshchandra Uchat	Director	25 Apr 2023	Current
Umang Alkesh Gosalia	Managing Director	02 Jan 2016	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	15 Oct 2011	Past
Pramod Abcsdd	Director	01 Oct 2010	Past
Pramod Abcsdd	Additional Director	16 Sep 2016	Past
Pramod Abcsdd	Additional Director	22 Sep 2018	Past
Pramod Abcsdd	Managing Director	13 Apr 2021	Past
Pramod Abcsdd	Company Secretary	25 Jul 2017	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Parmax Pharma.

Parmax Pharma Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 28.21% decrease. The company also saw a substantial fall in profitability, with a 5425.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 98.2%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-28.21%

*******

Revenue from Operations

*******

-28.34%

*******

Total Assets

*******

-12.96%

*******

Profit or Loss

*******

-5425.72%

*******

Net Worth

*******

-98.20%

*******

EBITDA

*******

-249.54%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Parmax Pharma?

In 2024, Parmax Pharma had a promoter holding of 30.83% and a public holding of 69.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹84,000,000.00

Satisfied Charges

₹149,618,350.00

Charges Breakdown by Lending Institutions

Others : 8.40 Cr

Latest Charge Details

Date	Lender	Amount	Status
17 Apr 2025	Others	₹8.40 Cr	Open
31 May 2023	Others	₹6.72 Cr	Satisfied
08 Feb 2019	Hdfc Bank Limited	₹1.12 Cr	Satisfied
16 Oct 2018	Hdfc Bank Limited	₹6.85 Cr	Satisfied
28 Jul 2017	Hdfc Bank Limited	₹2.67 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Parmax Pharma?

Parmax Pharma has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Parmax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parmax Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Parmax Pharma

Recent Activity within the Organization

Charges

The activity A charge with Others amounted to Rs. 8.40 Cr with Charge ID 101092470 was registered on 17 Apr 2025. was completed.
17 Apr 2025
Charges

A charge registered on 31 May 2023 via Charge ID 100775935 with Others was fully satisfied on 07 Apr 2025. was recorded as a recent event.
07 Apr 2025
Annual General Meeting

Parmax Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
30 Sep 2024
Director Appointment

Progress on Bhakti Rameshbhai Aghera was appointed as a Company Secretary was appointed as a Company Secretary on 17 May 2024 & has been associated with this company since 1 year 8 months . was documented.
17 May 2024
Balance Sheet

Progress on Parmax Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
31 Mar 2024
Charges

The activity A charge with Others of Rs. 6.72 Cr registered on 31 May 2023 with Charge ID 100775935 was modified on 10 Nov 2023. was completed.
10 Nov 2023

Explore recent activity and updates - View Recent Activity